These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11110045)

  • 1. Sudden unexpected death as a consequence of indinavir-induced nephropathy. A case report.
    Rajs J; Blaxhult A; Sundelin B
    APMIS; 2000 Sep; 108(9):581-3. PubMed ID: 11110045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
    Berns JS; Cohen RM; Silverman M; Turner J
    Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
    Squires KE; Gulick R; Tebas P; Santana J; Mulanovich V; Clark R; Yangco B; Marlowe SI; Wright D; Cohen C; Cooley T; Mauney J; Uffelman K; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1591-600. PubMed ID: 10983646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephropathy caused by crystal deposits induced by indinavir].
    Gonzalo A
    Nefrologia; 2001; 21(4):337. PubMed ID: 11816506
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients.
    Roca B; Gómez CJ; Arnedo A
    AIDS; 2000 Jan; 14(2):157-61. PubMed ID: 10708286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors.
    Reilly RF; Tray K; Perazella MA
    Am J Kidney Dis; 2001 Oct; 38(4):E23. PubMed ID: 11576910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
    Perazella MA; Kashgarian M; Cooney E
    Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indinavir-induced renal failure.
    Chen SC; Nankivell BJ; Dwyer DE
    AIDS; 1998 Mar; 12(4):440-1. PubMed ID: 9520176
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden anuria due to indinavir crystalluria.
    Anglicheau D; Duvic C; Nédélec G
    Nephron; 2000 Nov; 86(3):364-5. PubMed ID: 11096305
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
    Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic ketoacidosis in an HIV patient: a new mechanism of HIV protease inhibitor-induced glucose intolerance.
    Kan VL; Nylen ES
    AIDS; 1999 Oct; 13(14):1987-9. PubMed ID: 10513665
    [No Abstract]   [Full Text] [Related]  

  • 16. Papillary necrosis associated with the HIV protease inhibitor indinavir.
    Dieleman JP; van der Feltz M; Bangma CH; Stricker BH; van der Ende ME
    Infection; 2001 Aug; 29(4):232-3. PubMed ID: 11545487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urological management of indinavir-associated acute renal failure in HIV-positive patients.
    Kalaitzis C; Passadakis P; Giannakopoulos S; Panagoutsos S; Mpantis E; Triantafyllidis A; Touloupidis S; Vargemezis V
    Int Urol Nephrol; 2007; 39(3):743-6. PubMed ID: 17180736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.
    Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA
    AIDS; 2000 Jun; 14(9):1171-80. PubMed ID: 10894281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute tubulointerstitial nephritis attributable to indinavir therapy.
    Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
    Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.